Arrowhead Pharmaceuticals, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 74.2M |
| FY2017 | 73.9M |
| FY2018 | 83.6M |
| FY2019 | 98.6M |
| FY2020 | 100.7M |
| FY2021 | 103.7M |
| FY2022 | 105.4M |
| FY2023 | 106.8M |
| FY2024 | 119.8M |
| FY2025 | 133.8M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 74.2M |
| FY2017 | 73.9M |
| FY2018 | 83.6M |
| FY2019 | 98.6M |
| FY2020 | 100.7M |
| FY2021 | 103.7M |
| FY2022 | 105.4M |
| FY2023 | 106.8M |
| FY2024 | 119.8M |
| FY2025 | 133.8M |